Next Article in Journal
Pharmacological Profiling of KATP Channel Modulators: An Outlook for New Treatment Opportunities for Migraine
Next Article in Special Issue
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
Previous Article in Journal
Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women
Previous Article in Special Issue
Refractory Age-Related Macular Degeneration Due to Concurrent Central Serous Chorioretinopathy in Previously Well-Controlled Eyes
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(2), 224; https://doi.org/10.3390/ph16020224
Action Date Notes Link
article xml file uploaded 1 February 2023 10:26 CET Original file -
article xml uploaded. 1 February 2023 10:26 CET Update -
article pdf uploaded. 1 February 2023 10:26 CET Version of Record https://www.mdpi.com/1424-8247/16/2/224/pdf-vor
article supplementary file uploaded. 1 February 2023 10:26 CET - https://www.mdpi.com/1424-8247/16/2/224#supplementary
article html file updated 1 February 2023 10:27 CET Original file -
article xml file uploaded 6 February 2023 09:17 CET Update -
article xml uploaded. 6 February 2023 09:17 CET Update -
article pdf uploaded. 6 February 2023 09:17 CET Updated version of record https://www.mdpi.com/1424-8247/16/2/224/pdf-vor
article html file updated 6 February 2023 09:18 CET Update -
article xml file uploaded 8 February 2023 02:29 CET Update -
article xml uploaded. 8 February 2023 02:29 CET Update https://www.mdpi.com/1424-8247/16/2/224/xml
article pdf uploaded. 8 February 2023 02:29 CET Updated version of record https://www.mdpi.com/1424-8247/16/2/224/pdf
article html file updated 8 February 2023 02:30 CET Update https://www.mdpi.com/1424-8247/16/2/224/html
Back to TopTop